Le Lézard
Classified in: Covid-19 virus
Subjects: Personnel, Nonprofit

MITRE Names New Chief Technology Officer and Corporate Chief Engineer


MITRE's Charles Clancy, Ph.D., was named chief technology officer in addition to his role as senior vice president and general manager of MITRE Labs. He assumes management of the MITRE independent research and development (IR&D) program. Across these integrated responsibilities, Clancy leads MITRE's science, technology, and engineering workforce, the IR&D program, and extramural research activities. Dr. Jay Schnitzer, MITRE's senior vice president and chief medical officer, was named corporate chief engineer. He will help assure MITRE-wide technical quality and mission impact, support technical staff development, and continue as chief medical officer.

"Science and technology are critical to our nation's future in an era of global strategic competition," said Jason Providakes, Ph.D., MITRE president and CEO. "Charles will leverage MITRE's research activities to drive whole-of-nation impacts across MITRE's work with sponsors and partners in industry, academia, and other non-profit organizations. Jay will ensure our work meets the high bar of technical excellence needed to help our federal sponsors succeed in their missions and will continue to advance our cancer and quantum computing R&D programs."

Clancy joined MITRE in 2019 as the vice president for intelligence programs and was promoted to lead MITRE Labs in 2020. He previously served as the Bradley Distinguished Professor of Cybersecurity in the department of electrical and computer engineering at Virginia Tech, and earlier as a research leader at the National Security Agency. In 2022 he was named a fellow of the Institute for Electrical and Electronics Engineers for his work in secure and wireless communications.

Schnitzer joined MITRE in 2013 and has served as the company's chief technology officer for the past eight years. He previously led DARPA's defense sciences office, was Boston Scientific's chief medical officer, and worked over 15 years as an attending pediatric surgeon and associate professor of surgery at Massachusetts General Hospital, Shriners Children's Hospital Boston, and Harvard Medical School. He received the WashingtonExec 2020 Healthcare Industry Executive of the Year award for his work leading the COVID-19 Healthcare Coalition and was named to FCW's Fed 100 in 2023.

About MITRE

MITRE's mission-driven teams are dedicated to solving problems for a safer world. Through our public-private partnerships and federally funded R&D centers, we work across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation. Learn more at mitre.org.


These press releases may also interest you

at 16:45
CMC Metals Ltd. (CMCXF:OTCQB) ("CMC" or the "Company") announces that as a result of a review by the British Columbia Securities Commission ("BCSC"), the Company is issuing the following news to clarify previous...

at 16:40
The Board of Trustees of First Trust Energy Infrastructure Fund (the "Fund") , CUSIP 33738C103, previously approved a managed distribution policy for the Fund (the "Managed Distribution Plan") in reliance on exemptive relief received from the...

at 16:34
FGI Industries Ltd. ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced that it will issue financial results for the first quarter 2024 after the market close on Wednesday, May 8, 2024. Management will...

at 15:02
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

at 15:00
University of Phoenix College of Nursing is pleased to highlight the recent publication by alumna Gloria Littlemouse, Ph.D. in Nursing, MSN, RN, WCSI Scholar, whose dissertation study informed an article, "Lived Experiences of ICU Nurses During...

at 12:45
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff...



News published on and distributed by: